Literature DB >> 17030182

The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.

Jean Eric Ghia1, Patricia Blennerhassett, Harry Kumar-Ondiveeran, Elena F Verdu, Stephen M Collins.   

Abstract

BACKGROUND & AIMS: The recently proposed Inflammatory Reflex describes an interaction between the vagus nerve and peripheral macrophages, resulting in attenuation of proinflammatory cytokine release in response to systemic exposure to bacterial endotoxin. The purpose of this study was to determine whether a similar vagus/macrophage axis modulates the inflammatory responses in the colon in mice.
METHODS: We assessed the Disease Activity Index (DAI), macroscopic and histologic damage, serum amyloid-P level, and myeloperoxidase activity in colitis induced by administration of dextran sodium sulfate (DSS) in healthy and vagotomized C57BL/6 and in mice deficient in macrophage-colony stimulating factor (M-CSF)-induced and in hapten-induced colitis. A pyloroplasty was performed in vagotomized mice.
RESULTS: DAI, macroscopic and histologic scores, myeloperoxidase activity, levels of serum amyloid-P, and colonic tissue levels of interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha were increased significantly in vagotomized mice 5 days post-DSS and 3 days after hapten-induced colitis compared with sham-operated mice that received DSS or the hapten. Pretreatment with nicotine significantly decreased each of these markers in vagotomized mice with DSS colitis, and all markers except DAI and IL-6 in sham-operated DSS-treated mice. Conversely, hexamethonium treatment significantly increased each of these markers in the sham-operated DSS-treated mice. Vagotomy had no effect on the colitis in M-CSF-deficient mice.
CONCLUSIONS: The vagus nerve plays a counterinflammatory role in acute colitis via a macrophage-dependent mechanism, involving hexamethonium-sensitive nicotinic receptors. The identification of a counterinflammatory neural pathway would open new therapeutic avenues for treating acute exacerbations of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030182     DOI: 10.1053/j.gastro.2006.08.016

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  134 in total

1.  Efferent vagal nerve stimulation attenuates gut barrier injury after burn: modulation of intestinal occludin expression.

Authors:  Todd W Costantini; Vishal Bansal; Carrie Y Peterson; William H Loomis; James G Putnam; Fermin Rankin; Paul Wolf; Brian P Eliceiri; Andrew Baird; Raul Coimbra
Journal:  J Trauma       Date:  2010-06

Review 2.  Mechanisms and Therapeutic Relevance of Neuro-immune Communication.

Authors:  Sangeeta S Chavan; Valentin A Pavlov; Kevin J Tracey
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

3.  Electroacupuncture activates enteric glial cells and protects the gut barrier in hemorrhaged rats.

Authors:  Sen Hu; Zeng-Kai Zhao; Rui Liu; Hai-Bin Wang; Chun-Yu Gu; Hong-Min Luo; Huan Wang; Ming-Hua Du; Yi Lv; Xian Shi
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 4.  Cholinergic control of inflammation.

Authors:  M Rosas-Ballina; K J Tracey
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

5.  Cholinergic modulation of inflammation.

Authors:  Valentin A Pavlov
Journal:  Int J Clin Exp Med       Date:  2008-06-05

Review 6.  Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.

Authors:  N Y Lai; K Mills; I M Chiu
Journal:  J Intern Med       Date:  2017-02-02       Impact factor: 8.989

7.  Anti-inflammatory effect and mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats and mice.

Authors:  Xiaoli Gao; Qi Sun; Weiwei Zhang; Yimin Jiang; Runtao Li; Jia Ye
Journal:  Inflamm Res       Date:  2018-01-04       Impact factor: 4.575

Review 8.  Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation.

Authors:  Bruno Bonaz; Valérie Sinniger; Sonia Pellissier
Journal:  J Physiol       Date:  2016-05-01       Impact factor: 5.182

9.  The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage.

Authors:  Masahiko Fujisawa; Takahisa Murata; Masatoshi Hori; Hiroshi Ozaki
Journal:  J Gastroenterol       Date:  2009-12-10       Impact factor: 7.527

10.  Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.

Authors:  Jean-Eric Ghia; Patricia Blennerhassett; Stephen M Collins
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.